---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-197046"
form_type: "8-K"
ticker: "AGEN"
cik: "0001098972"
company_name: "AGENUS INC"
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T10:40:41.619048+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Agenus Q2 net loss $54.8M, advances BOT/BAL in CRC; appoints director; files ATM for up to 13.8M shares

## Summary
- Q2 net loss $54.8M, revenue $23.5M (incl $22.6M non-cash royalty); cash $93.7M at June 30 vs $76.1M Dec 31.
- BOT/BAL in r/r MSS CRC: RECIST ORR 19.4% in selected cohort; 90% 6-month OS; FDA discouraged AA submission; plan to refile with mature data.
- NEST-2 neoadjuvant CRC: 56% (5/9) patients achieved complete pathologic responses; 78% had ≥50% tumor reduction.
- Appointed Thomas L. Harrison to Board as Class III director; granted option for 7,500 shares vesting over 3 years.
- Filed prospectus supplement for ATM offering of up to 13,843,015 shares under existing B. Riley sales agreement.

## SEC filing metadata
- accession: 0001193125-24-197046
- form_type: 8-K
- ticker: AGEN
- cik: 0001098972
- company_name: AGENUS INC
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1098972/000119312524197046/0001193125-24-197046-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1098972/000119312524197046/d800799d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-197046
- JSON: https://secwatch.observer/filing/0001193125-24-197046.json
- Plain text: https://secwatch.observer/filing/0001193125-24-197046.txt

## Key facts
- Executive change
  Thomas L. Harrison was elected as Class III director at AGENUS INC.
  - Action: elected
  - Role: Class III director
  source text: On August 7, 2024, the Board of Directors (the “Board”) of Agenus elected Thomas L. Harrison to become a Class III director of Agenus with an initial term that expires at Agenus’s annual meeting of stockholders in 2027.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1098972/000119312524197046/0001193125-24-197046-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.